Jeffrey Khan, Director of Institute of Bioethics, Johns Hopkins University

Jeffrey Kahn, a prominent figure in the field of bioethics, has been named for a second term as the Andreas C. Dracopoulos Director of the Johns Hopkins Berman Institute of Bioethics. Since 2016, Kahn has led the institute, enhancing its global reputation and fostering collaborations across Johns Hopkins University.

Under Kahn’s guidance, the Berman Institute achieved significant milestones:

Ethical COVID-19 Response: Collaborated with global partners to ensure ethical public health strategies during the pandemic.

Educational Funding: Secured the institute’s largest-ever donation, endowing educational programs and scholarships.

International Partnerships: Established a partnership on infectious disease ethics with the University of Oxford.

Innovative Initiatives: Launched the Dracopoulos-Bloomberg Bioethics iDeas Lab to pioneer novel approaches in bioethics communication.

Global Training: Initiated bioethics training programs for health professionals worldwide.

Kahn also expanded the master’s program, increased diversity among faculty, and led efforts for inclusion and equity. His reappointment reflects his exceptional leadership and commitment to advancing ethical discourse in the rapidly evolving landscape of health and science.

“Leading the Berman Institute is a privilege,” Kahn said. “I eagerly anticipate steering the institute into its next chapter as it tackles emerging ethical and policy challenges.”

In addition to his role at the Berman Institute, Kahn maintains an active research agenda focused on public health ethics and life sciences policies. He is recognized as a key contributor to national and international dialogues, as exemplified by his leadership in the NIH-funded BRIDGES project.

Kahn’s reappointment shows commitment to the continued growth and influence of the Berman Institute, fortifying its position as a global hub for cutting-edge bioethics exploration and education.